Walleye Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2M | Buy |
189,800
+71,700
| +61% | +$5.91M | 0.03% | 608 |
|
|
2025
Q4 | $10.1M | Buy |
118,100
+49,800
| +73% | +$4.09M | 0.01% | 924 |
|
|
2025
Q3 | $5.31M | Sell |
68,300
-81,000
| -54% | -$6.33M | 0.01% | 1225 |
|
|
2025
Q2 | $11.7M | Sell |
149,300
-93,800
| -39% | -$7M | 0.02% | 736 |
|
|
2025
Q1 | $17.6M | Buy |
243,100
+103,600
| +74% | +$7.42M | 0.04% | 484 |
|
|
2024
Q4 | $10.3M | Buy |
139,500
+89,500
| +179% | +$6.26M | 0.02% | 769 |
|
|
2024
Q3 | $3.3M | Buy |
50,000
+11,900
| +31% | +$865K | 0.01% | 1367 |
|
|
2024
Q2 | $3.52M | Buy |
38,100
+10,500
| +38% | +$930K | 0.01% | 1261 |
|
|
2024
Q1 | $2.64M | Sell |
27,600
-63,400
| -70% | -$5.33M | 0.01% | 1562 |
|
|
2023
Q4 | $6.94M | Buy |
91,000
+7,300
| +9% | +$508K | 0.01% | 1026 |
|
|
2023
Q3 | $5.8M | Buy |
83,700
+10,300
| +14% | +$828K | 0.02% | 1014 |
|
|
2023
Q2 | $6.92M | Buy |
73,400
+16,000
| +28% | +$1.39M | 0.02% | 753 |
|
|
2023
Q1 | $4.75M | Buy |
57,400
+21,800
| +61% | +$1.71M | 0.01% | 1083 |
|
|
2022
Q4 | $2.66M | Sell |
35,600
-85,100
| -71% | -$6.56M | 0.01% | 1493 |
|
|
2022
Q3 | $9.97M | Buy |
120,700
+113,400
| +1,553% | +$10.9M | 0.03% | 625 |
|
|
2022
Q2 | $694K | Buy |
7,300
+1,500
| +26% | +$155K | ﹤0.01% | 2595 |
|
|
2022
Q1 | $683K | Buy |
5,800
+4,600
| +383% | +$516K | ﹤0.01% | 2596 |
|
|
2021
Q4 | $155K | Sell |
1,200
-8,600
| -88% | -$1M | ﹤0.01% | 4097 |
|
|
2021
Q3 | $1.11M | Buy |
9,800
+8,500
| +654% | +$970K | ﹤0.01% | 2093 |
|
|
2021
Q2 | $135K | Buy |
1,300
+800
| +160% | +$75.4K | ﹤0.01% | 4222 |
|
|
2021
Q1 | $42K | Sell |
500
-10,400
| -95% | -$879K | ﹤0.01% | 4376 |
|
|
2020
Q4 | $994K | Sell |
10,900
-17,200
| -61% | -$1.43M | ﹤0.01% | 1974 |
|
|
2020
Q3 | $2.24M | Buy |
28,100
+2,400
| +9% | +$187K | 0.01% | 1045 |
|
|
2020
Q2 | $1.78M | Buy |
25,700
+13,100
| +104% | +$931K | 0.01% | 1201 |
|
|
2020
Q1 | $792K | Sell |
12,600
-24,000
| -66% | -$1.73M | 0.01% | 1481 |
|
|
2019
Q4 | $2.85M | Buy |
36,600
+17,100
| +88% | +$1.34M | 0.02% | 947 |
|
|
2019
Q3 | $1.43M | Sell |
19,500
-37,800
| -66% | -$2.66M | 0.01% | 1332 |
|
|
2019
Q2 | $3.53M | Buy |
57,300
+21,900
| +62% | +$1.32M | 0.03% | 661 |
|
|
2019
Q1 | $2.26M | Sell |
35,400
-13,800
| -28% | -$788K | 0.02% | 976 |
|
|
2018
Q4 | $2.51M | Buy |
49,200
+12,900
| +36% | +$653K | 0.02% | 904 |
|
|
2018
Q3 | $2.11M | Buy |
36,300
+24,600
| +210% | +$1.2M | 0.01% | 1277 |
|
|
2018
Q2 | $568K | Sell |
11,700
-6,900
| -37% | -$322K | ﹤0.01% | 2718 |
|
|
2018
Q1 | $865K | Sell |
18,600
-6,000
| -24% | -$261K | 0.01% | 2067 |
|
|
2017
Q4 | $924 | Buy |
24,600
+2,400
| +11% | +$88.1K | ﹤0.01% | 2002 |
|
|
2017
Q3 | $810 | Sell |
22,200
-9,900
| -31% | -$378K | ﹤0.01% | 2063 |
|
|
2017
Q2 | $1.26K | Buy |
32,100
+3,900
| +14% | +$142K | 0.01% | 1561 |
|
|
2017
Q1 | $882 | Buy |
28,200
+9,900
| +54% | +$310K | 0.01% | 1748 |
|
|
2016
Q4 | $571K | Sell |
18,300
-3,300
| -15% | -$107K | ﹤0.01% | 1977 |
|
|
2016
Q3 | $867K | Sell |
21,600
-30,000
| -58% | -$1.13M | 0.01% | 1665 |
|
|
2016
Q2 | $1.72M | Buy |
51,600
+20,100
| +64% | +$688K | 0.01% | 1125 |
|
|
2016
Q1 | $928K | Sell |
31,500
-33,600
| -52% | -$927K | 0.01% | 1467 |
|
|
2015
Q4 | $1.72M | Buy |
65,100
+21,300
| +49% | +$553K | 0.02% | 857 |
|
|
2015
Q3 | $1.04M | Sell |
43,800
-23,400
| -35% | -$565K | 0.01% | 1029 |
|
|
2015
Q2 | $1.59M | Buy |
67,200
+14,400
| +27% | +$325K | 0.02% | 840 |
|
|
2015
Q1 | $1.25M | Sell |
52,800
-30,600
| -37% | -$686K | 0.01% | 886 |
|
|
2014
Q4 | $1.77M | Sell |
83,400
-54,600
| -40% | -$1.1M | 0.02% | 739 |
|
|
2014
Q3 | $2.35M | Buy |
138,000
+36,600
| +36% | +$578K | 0.03% | 372 |
|
|
2014
Q2 | $1.46K | Buy |
101,400
+27,000
| +36% | +$366K | 0.02% | 575 |
|
|
2014
Q1 | $919 | Sell |
74,400
-219,000
| -75% | -$2.53M | 0.01% | 907 |
|
|
2013
Q4 | $3.22M | Buy |
293,400
+230,400
| +366% | +$2.6M | 0.03% | 448 |
|
|
2013
Q3 | $731K | Buy |
63,000
+14,400
| +30% | +$168K | 0.01% | 1020 |
|
|
2013
Q2 | $544K | Buy |
+48,600
| New | +$575K | 0.01% | 1202 |
|
Other funds holding EW
VCM
VPM
Walleye Trading's EW Position: Q1 2026 in Review
Walleye Trading increased its Edwards Lifesciences (EW) stake by 21% in Q1 2026, buying an estimated $74.2K and bringing the position to 5,124 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.
Walleye Trading first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $4.77M in Q3 2018. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Walleye Trading held 5,124 shares of Edwards Lifesciences worth $410K as of Q1 2026.
- Walleye Trading bought 900 Edwards Lifesciences shares in Q1 2026, an estimated $74.2K.
- Edwards Lifesciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2710 holding.
- Walleye Trading first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
- Walleye Trading's Edwards Lifesciences position peaked at $4.77M in Q3 2018.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.